IN2014DE01467A - - Google Patents
Info
- Publication number
- IN2014DE01467A IN2014DE01467A IN1467DE2014A IN2014DE01467A IN 2014DE01467 A IN2014DE01467 A IN 2014DE01467A IN 1467DE2014 A IN1467DE2014 A IN 1467DE2014A IN 2014DE01467 A IN2014DE01467 A IN 2014DE01467A
- Authority
- IN
- India
- Prior art keywords
- hot
- melt
- temperature
- drug
- melt extrusion
- Prior art date
Links
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 abstract 5
- 238000009474 hot melt extrusion Methods 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 239000012943 hotmelt Substances 0.000 abstract 4
- -1 hydroxypropoxy Chemical group 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 230000009849 deactivation Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B13/00—Preparation of cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
- C08J3/201—Pre-melted polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/32—Cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/08—Cellulose derivatives
- C08J2301/32—Cellulose ether-esters
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013116836 | 2013-06-03 | ||
JP2013246178 | 2013-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DE01467A true IN2014DE01467A (pt) | 2015-07-24 |
Family
ID=50842156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1467DE2014 IN2014DE01467A (pt) | 2013-06-03 | 2014-06-03 |
Country Status (8)
Country | Link |
---|---|
US (2) | US10016508B2 (pt) |
EP (2) | EP2810660B1 (pt) |
JP (2) | JP6007322B2 (pt) |
KR (2) | KR102228157B1 (pt) |
CN (2) | CN104208713B (pt) |
IN (1) | IN2014DE01467A (pt) |
PT (2) | PT3006049T (pt) |
WO (1) | WO2014196519A1 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014DE01467A (pt) * | 2013-06-03 | 2015-07-24 | Shinetsu Chemical Co | |
JP6203702B2 (ja) | 2014-11-18 | 2017-09-27 | 信越化学工業株式会社 | ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法 |
EP3998258A1 (en) | 2014-12-18 | 2022-05-18 | Merck Sharp & Dohme Corp. | (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl- 1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations |
JP6725534B2 (ja) * | 2015-05-15 | 2020-07-22 | ダウ グローバル テクノロジーズ エルエルシー | 極めて高い分子量及び低い粘度のエステル化セルロースエーテルの生成プロセス |
CN107567463A (zh) * | 2015-05-15 | 2018-01-09 | 陶氏环球技术有限责任公司 | 制备高分子量酯化纤维素醚的工艺 |
WO2017019276A1 (en) * | 2015-07-28 | 2017-02-02 | Dow Global Technologies Llc | Process for producing dispersion of esterified cellulose ether |
EP3596132B1 (en) | 2017-03-17 | 2021-05-05 | Nutrition & Biosciences USA 1, LLC | Process for recovering an esterified cellulose ether from a reaction product mixture |
WO2018170083A1 (en) | 2017-03-17 | 2018-09-20 | Dow Global Technologies Llc | Process for recovering an esterified cellulose ether from a reaction product mixture |
MX2019010712A (es) | 2017-03-17 | 2019-10-21 | Dow Global Technologies Llc | Proceso para recuperar un eter de celulosa esterificado a partir de una mezcla de producto de reaccion. |
US20180282527A1 (en) | 2017-03-30 | 2018-10-04 | Shin-Etsu Chemical Co., Ltd. | Injection molding composition containing hypromellose acetate succinate and method for producing same |
CN109078186B (zh) * | 2017-06-14 | 2021-09-03 | 江苏恒瑞医药股份有限公司 | 一种胃漂浮组合物及其制备方法 |
TR201722852A2 (tr) * | 2017-12-29 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Mesalazi̇ni̇n oral farmasöti̇k kompozi̇syonlari |
WO2020131801A1 (en) | 2018-12-18 | 2020-06-25 | DDP Specialty Electronic Materials US, Inc. | A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate |
JP7050714B2 (ja) * | 2019-04-04 | 2022-04-08 | 信越化学工業株式会社 | 腸溶性コーティング用組成物及び固形製剤の製造方法 |
JP7252882B2 (ja) * | 2019-11-01 | 2023-04-05 | 信越化学工業株式会社 | ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法 |
JP7273691B2 (ja) | 2019-11-01 | 2023-05-15 | 信越化学工業株式会社 | ヒドロキシプロピルメチルセルロースフタレートの製造方法 |
WO2021118915A1 (en) | 2019-12-09 | 2021-06-17 | Nutrition & Biosciences Usa 1, Llc | Hydroxypropyl alkyl cellulose acetate succinate heteropolymers |
WO2022034232A1 (en) | 2020-08-13 | 2022-02-17 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Gastro-resistant high-strength formulation containing posaconazole |
JP7399060B2 (ja) | 2020-10-01 | 2023-12-15 | 信越化学工業株式会社 | ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法 |
EP4091604B1 (en) | 2021-11-25 | 2024-04-03 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Granules containing posaconazole |
CN115581678B (zh) * | 2022-11-04 | 2023-09-12 | 北京鑫开元医药科技有限公司 | 一种瑞派替尼片组合物及其制备方法 |
CN115651085B (zh) * | 2022-11-14 | 2023-11-17 | 乳源东阳光药业有限公司 | 一种醋酸羟丙甲纤维素琥珀酸酯的纯化方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3852421A (en) | 1970-03-23 | 1974-12-03 | Shinetsu Chemical Co | Excipient and shaped medicaments prepared therewith |
US4226981A (en) | 1977-09-28 | 1980-10-07 | Shin-Etsu Chemical Co., Ltd. | Ether-ester derivatives of cellulose and their applications |
JPS5951562B2 (ja) * | 1977-10-25 | 1984-12-14 | 信越化学工業株式会社 | セルロ−スエ−テルの酸性サクシニルおよび脂肪族モノアシル混成エステルの製造方法 |
US4266981A (en) | 1978-03-08 | 1981-05-12 | Purdue Research Corporation | Process for recovering and utilizing cellulose using sulfuric acid |
DE19504832A1 (de) * | 1995-02-14 | 1996-08-22 | Basf Ag | Feste Wirkstoff-Zubereitungen |
AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
JPWO2003077827A1 (ja) | 2002-03-19 | 2005-07-14 | 日本新薬株式会社 | 医薬固体分散体の製造方法 |
KR100454394B1 (ko) | 2002-03-27 | 2004-10-26 | 이원희 | 맥파검출장치 |
JP4344914B2 (ja) | 2003-02-28 | 2009-10-14 | 信越化学工業株式会社 | アルカリ溶解性カルボン酸エステル系セルロース誘導体及び該誘導体からなるフィルム |
US8207232B2 (en) * | 2004-05-28 | 2012-06-26 | Bend Research, Inc. | Pharmaceutical compositions with enhanced performance |
CA2621800A1 (en) * | 2005-09-06 | 2007-03-15 | Astellas Pharma Inc. | Fine particles of poorly soluble drug having enteric base material adsorbed on the surface thereof |
JP5576922B2 (ja) * | 2006-04-20 | 2014-08-20 | 信越化学工業株式会社 | 腸溶性固体分散体を含んでなる固形製剤 |
JP5052051B2 (ja) * | 2006-06-16 | 2012-10-17 | トーアエイヨー株式会社 | 腸溶性顆粒剤及びその製造方法 |
JP5070618B2 (ja) * | 2006-06-16 | 2012-11-14 | トーアエイヨー株式会社 | 腸溶性顆粒剤及びその製造方法 |
CN101686994B (zh) * | 2006-10-20 | 2013-05-01 | 陶氏环球技术公司 | 水溶性纤维素衍生物制备用于预防或治疗代谢综合征的药物等的用途 |
KR20110004852A (ko) * | 2008-04-15 | 2011-01-14 | 쉐링 코포레이션 | 포사코나졸 및 hpmcas를 바람직하게 포함하는 고체 분산액 중의 경구 약제학적 조성물 |
US20110034478A1 (en) | 2008-04-15 | 2011-02-10 | Schering-Plough Corporation | Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAs |
EP2354825B1 (en) | 2010-02-03 | 2015-07-15 | Tyco Electronics Nederland B.V. | Enclosure assembly for a connector, strain relief element, and method |
WO2011159626A1 (en) | 2010-06-14 | 2011-12-22 | Bend Research, Inc. | Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
US8409560B2 (en) * | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
JP2014507424A (ja) * | 2011-03-08 | 2014-03-27 | ザリカス ファーマスーティカルズ リミテッド | 固体分散物製剤およびその使用方法 |
US20120251588A1 (en) * | 2011-03-30 | 2012-10-04 | Miyuki Fukasawa | Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation |
JP2013116836A (ja) | 2011-12-02 | 2013-06-13 | Sharp Corp | シリコン端材の再利用方法並びに原料シリコン、多結晶シリコン材料及び多結晶シリコン太陽電池の製造方法 |
DE102012010430A1 (de) | 2012-05-29 | 2013-12-05 | Krohne Ag | Durchflussmessgerät |
WO2014031422A1 (en) | 2012-08-24 | 2014-02-27 | Dow Global Technologies Llc | Novel hydroxyalkyl methyl cellulose acetate succinates |
IN2014DE01467A (pt) * | 2013-06-03 | 2015-07-24 | Shinetsu Chemical Co |
-
2014
- 2014-06-03 IN IN1467DE2014 patent/IN2014DE01467A/en unknown
- 2014-06-03 WO PCT/JP2014/064711 patent/WO2014196519A1/ja active Application Filing
- 2014-06-03 CN CN201410242677.6A patent/CN104208713B/zh active Active
- 2014-06-03 JP JP2015521450A patent/JP6007322B2/ja active Active
- 2014-06-03 US US14/294,258 patent/US10016508B2/en active Active
- 2014-06-03 PT PT148069453T patent/PT3006049T/pt unknown
- 2014-06-03 US US14/892,421 patent/US10646573B2/en active Active
- 2014-06-03 KR KR1020157034116A patent/KR102228157B1/ko active IP Right Grant
- 2014-06-03 KR KR1020140067370A patent/KR101918327B1/ko active IP Right Grant
- 2014-06-03 EP EP14170863.6A patent/EP2810660B1/en active Active
- 2014-06-03 JP JP2014114900A patent/JP6126555B2/ja active Active
- 2014-06-03 PT PT141708636T patent/PT2810660T/pt unknown
- 2014-06-03 CN CN201480030211.8A patent/CN105283203B/zh active Active
- 2014-06-03 EP EP14806945.3A patent/EP3006049B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN105283203A (zh) | 2016-01-27 |
CN104208713A (zh) | 2014-12-17 |
CN104208713B (zh) | 2018-04-27 |
EP3006049A1 (en) | 2016-04-13 |
EP3006049B1 (en) | 2018-02-28 |
US10646573B2 (en) | 2020-05-12 |
US10016508B2 (en) | 2018-07-10 |
PT3006049T (pt) | 2018-03-20 |
KR102228157B1 (ko) | 2021-03-17 |
KR101918327B1 (ko) | 2018-11-13 |
JP6126555B2 (ja) | 2017-05-10 |
KR20140142173A (ko) | 2014-12-11 |
EP2810660A1 (en) | 2014-12-10 |
CN105283203B (zh) | 2018-12-28 |
JP2015127316A (ja) | 2015-07-09 |
US20160095928A1 (en) | 2016-04-07 |
KR20160015234A (ko) | 2016-02-12 |
WO2014196519A1 (ja) | 2014-12-11 |
JP6007322B2 (ja) | 2016-10-12 |
EP2810660B1 (en) | 2017-07-26 |
EP3006049A4 (en) | 2017-02-22 |
JPWO2014196519A1 (ja) | 2017-02-23 |
US20140357681A1 (en) | 2014-12-04 |
PT2810660T (pt) | 2017-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DE01467A (pt) | ||
EP4272746A3 (en) | Crystal forms of beta-nicotinamide mononucleotide | |
EP3452026A4 (en) | METHODS OF MANUFACTURE, COMPOSITIONS AND MEDICAL APPLICATIONS OF ORAL-ADDED CANNABIS-BASED PHARMACEUTICAL PRODUCTS | |
PH12014502324A1 (en) | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same | |
NZ731789A (en) | Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof | |
MX2021007268A (es) | Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas. | |
EP3283470A4 (en) | Processes for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom | |
IN2014DE02197A (pt) | ||
TW201711997A (en) | 2-arylamino pyridine, pyridine or triazine derivative, preparation method and use thereof | |
WO2015017478A3 (en) | SYNTHESIS OF CdSe/ZnS CORE/SHELL SEMICONDUCTOR NANOWIRES | |
MX2016002998A (es) | Derivados novedosos de ftalazinona y su procedimiento de fabricacion. | |
MX2018005741A (es) | Composicion para el cuidado de mascotas. | |
MX2019000536A (es) | Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1. | |
EP3440192A4 (en) | PREPARATION OF FULLY OPERATIONAL TIRE BETA CELLS FROM HUMAN PANCREATIC FOREIGNERS | |
EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
WO2014121764A3 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
EP4327880A3 (en) | Solid state form of ribociclib succinate | |
EP3318591A4 (en) | A MONOPERATED HETEROPOLYETHYLENE GLYCOL, INTERMEDIATE PRODUCT FOR PREPARING A MONOPHAPED HETEROPOLYETHYLENE GLYCOL, METHOD FOR THE PREPARATION THEREOF, AND MONODISPERLATED HETEROPOLYETHYLENE GLYCOL CONJUGATE | |
PH12021550413A1 (en) | Vitamin d pediatric dosage forms, methods of making and using | |
MX2015012305A (es) | Proceso para formar un articulo para el cuidado personal. | |
EP2939663A4 (en) | MELT EXTRUDED PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE AND MEDICAMENT FOR ORAL ADMINISTRATION THEREWITH | |
EP3083548A4 (en) | Direct synthesis of bio-based alkyl&furanic diol ethers, acetates, ether-acetates, and carbonates | |
MX2015016603A (es) | Composiciones de corticosteroides. | |
WO2016161988A3 (zh) | 一种含有球形硫酸氢氯吡格雷i晶型的药物组合物及其制备方法 | |
Querol et al. | First assessment of acceptance of dry extruded diets for Octopus vulgaris (Cuvier, 1797). |